Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro

Planta Medica

Volumn 72, Issue 1, 2006, Pages 4-8

  Zhang, Wei Dong ^a,c   Chen, Hong ^a,b   Zhang, Chuan ^a   Liu, Run Hui ^a   Li, Hui Liang ^a   Chen, Hong Zhuan ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Astragaloside IV; Cardioprotection; Ischemia; Nitric oxide; Superoxide dismutase

Indexed keywords

ASTRAGALOSIDE IV; ASTRAGALUS MEMBRANACEUS EXTRACT; HERBACEOUS AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SALVIA MILTIORRHIZA EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASTRAGALUS MEMBRANACEUS; CHINA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY LIGATION; DOG; DRUG MECHANISM; ENZYME ACTIVITY; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN;

ANIMALS; ASTRAGALUS MEMBRANACEUS; DOGS; MALE; MOLECULAR STRUCTURE; MYOCARDIAL ISCHEMIA; NITRIC OXIDE SYNTHASE TYPE III; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, SPRAGUE-DAWLEY; SALVIA MILTIORRHIZA; SAPONINS; SUPEROXIDE DISMUTASE; TRITERPENES;

ANIMALIA; ASTRAGALUS MEMBRANACEUS; CANIS FAMILIARIS; SALVIA MILTIORRHIZA;

EID: 32644451004     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-873126     Document Type: Article

References (23)

1. Li SQ, Yuan RX, Gao H, Wang YQ. Clinical observation on treatment of ischemic heart disease with Astragalus membranaceus. Chin J Integr Trad Western Med 1995; 15: 77-80
2. Miller AL. Botanical influences on cardiovascular disease. Altern Med Rev 1998; 3: 422-31
3. Zhou S, Shao W, Wang W. Clinical study of Astragalus injection plus ligustrazine in protecting myocardial ischemia reperfusion injury. Chin J Integr Trad Western Med 2000; 20: 504-7
4. Sun CW, Lü WW, Lei CL, Wu Y, Chen Y. Effetts of Astragalus saponins on experimental heart failure. J N Berthune Univ Med School 1994; 20: 125-7
5. Zhou JY, Fan Y, Kong JL, Wu DZ, Hu ZB. Effects of components isolated from Astragalus membranaceus Bunge on cardiac function injured by myocardial ischemia reperfusion in rats. China J Chin Mater Medica 2000; 25: 300-2
6. Wang HK, He K, Ye JL. Chemical constituents of Astragalus mongholicus. Chin Tradit Herb Drugs 1987; 18: 5-7
7. Ji X, Tan BK, Zhu YC, Linz W, Zhu YZ. Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats. Life Sci 2003; 73: 1413-26
8. Chen LB, Liu T, Wu JX, Chen XF, Wang L, Fan CL et al. Hypertonic perfusion reduced myocardial injury during subsequent ischemia and reperfusion in normal and hypertensive rats. Acta Pharmacol Sin 2003; 24: 1077-82
9. Curtis MJ, Walker MJ. Quantification of arrhythmia using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res 1988; 22: 656-65
10. Shi GG, Chen JC, Li ZC, Liu XP. Direct effect of Astragalus membranaceus on coronary artery. Trad Chin Drug Res Clin Pharmacol 1999; 10: 38-9
11. Michel T, Feron O. Nitric oxide: which, where, how and why? J Clin Invest 1997; 100: 2146-52
12. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100: 2417-24
13. Koboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo. Circulation 2000; 101: 676-81
14. Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. J Biol Chem 1996; 271: 29223-30
15. Ma XL, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993; 72: 403-12
16. Rochetaing A, Kreher P. Reactive hyperemia during early reperfusion as a determinant of improved functional recovery in ischemic preconditioned rat hearts. J Thorac Cardiovasc Surg 2003; 125: 1516-25
17. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad and ugly. Am J Physiol 1996; 271: C1424C37
18. Kobara M, Tatsumi T, Takeda M, Mano A, Yamanaka S, Shiraishi J et al. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts. Basic Res Cardiol 2003; 98: 319-28
19. Narang D, Sood S, Thomas MK, Dinda AK, Maulik SK. Effect of dietary palm olein oil on oxidative stress associated with ischemic-reperfusion injury in isolated rat heart. BMC Pharmacol 2004; 4: 29
20. (+)-ATPase isoform expression in rat heart. Antioxid Redox Signal 2004; 6: 914-23
21. Gupta SK, Mohanty I, Talwar KK, Dinda A, Joshi S, Bansal P et al. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. Mol Cell Biochem 2004; 260: 39-47
22. - and OH. J Chin Med Mat 1999; 22: 303-6
23. Luo Y, Qin Z, Hong Z, Zhang X, Ding D, Fu JH et al. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci Lett 2004; 363: 218-23